Vaccine Booster Trial for Public Slated for December 2021

Translator:

Editor:

Laila Afifa

  • Font:
  • Ukuran Font: - +
  • The vaccinator inserts a dose of Moderna vaccine into a syringe before it is injected to health workers as a third or booster dose of vaccine at the Matraman Regional General Hospital, Jakarta, Friday, August 6, 2021. Giving a third dose of vaccine or booster to health workers, assistant workers health and support personnel who work in health care facilities, are still being implemented. The administration of the third dose of vaccine or booster is targeted to be completed in the second week of August 2021. TEMPO / Hilman Fathurrahman W

    The vaccinator inserts a dose of Moderna vaccine into a syringe before it is injected to health workers as a third or booster dose of vaccine at the Matraman Regional General Hospital, Jakarta, Friday, August 6, 2021. Giving a third dose of vaccine or booster to health workers, assistant workers health and support personnel who work in health care facilities, are still being implemented. The administration of the third dose of vaccine or booster is targeted to be completed in the second week of August 2021. TEMPO / Hilman Fathurrahman W

    TEMPO.CO, Jakarta - The team of researchers from the faculty of medicines at Padjadjaran University and University of Indonesia are set to conduct research for Covid-19 vaccine booster for the general public. The current booster rollout is exclusively given to medical healthcare workers, and is not based on home-grown research. 

    “We will conduct another research after being trusted by the WHO and Health Ministry to do  the research on the vaccine boosters,” said Eddy Fadlyana, Head of the research team on Thursday, October 14. 

    This research will be used as a basis for future government policies regarding booster shots, and to find out whether it would be effective to increase the immunity of people at a border range. In terms of WHO’s interests, this study will find the effects of booster shots in the six months after it is administered. 

    “Those who have been vaccinated will be checked for their antibody after one month while the WHO will monitor the effects for 6 months,” said the pediatrician at Central General Hospital dr. Hasan Sadikin Bandung. 

    This research is scheduled to begin in December and is handled by 100 team members involving 1,500 volunteers where its recruitment will be announced in November. The research itself will be conducted in Bandung and Jakarta. 

    Vaccine brands used in this research range from Sinovac, AstraZeneca, and Pfizer. Fadlyana was also trusted to lead the previous third clinical test for Sinovac vaccines in Indonesia. 

    Read: Administering Vaccine Boosters Not Viable With Limited Supply: Govt

    ANWAR SISWADI (CONTRIBUTOR)